UPC Analytics
ENDE
Overview · Filed:

ACT_16120/2024

NOVEL ANTITUMORAL USE OF CABAZITAXEL

InfringementMain Infringement ActionMunich LDInfringement Action
Substantive event Case management AppellateDotted = low-confidence date
Other dated event
Aug 8, 202
Interim conference
Sep 12, 20
procedural_only
Sep 15, 20
Oral hearing scheduled
Oct 14, 20
Witness hearing
Oct 14, 20